Cellular Research
NAD+
NAD+ 500 mg (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme, not a peptide, supplied as a research compound; the published lot report shows 99.45% HPLC purity.
99.45% HPLC purity · Lot report published
MASS
BUY ONE, GET ONE FREE · APPLIED IN YOUR CART
$69.99
Availability: In stock (can be backordered)
CHEMICAL BLOCK
The data your lab notebook needs.
Identity data for this material. Published lot reports, where one exists, are in the lab report library.
| FORM | Lyophilized Powder |
|---|---|
| PURITY | Per lot (see published lab report) |
| STORAGE | Lyophilized (powder): −20°C, away from light, unopened |
COMMON QUESTIONS
Everything researchers ask before ordering.
Compound information
NAD+ research data.
Nicotinamide adenine dinucleotide, oxidized form (a coenzyme, not a peptide)
NAD+ (nicotinamide adenine dinucleotide, oxidized form; INN nadide) is a coenzyme, not a peptide. It is a dinucleotide: adenosine monophosphate and nicotinamide mononucleotide joined through a pyrophosphate bridge. NAD+ accepts a hydride ion to give NADH, and the two form a redox pair. The compound was first described by Arthur Harden and William Young in 1906 as the heat-stable 'cozymase' fraction of yeast extract.
NAD+ is one of the most widely studied small molecules in biochemistry. Published work spans the enzymology of NAD+-dependent dehydrogenases, crystal structures of NAD+-bound proteins, biosynthetic pathway chemistry and analytical methods. The references below are analytical papers on extracting and quantifying NAD+ and related nucleotides by liquid chromatography and mass spectrometry.
| Type | Dinucleotide coenzyme (not a peptide) |
|---|---|
| Also listed as | NAD, nicotinamide adenine dinucleotide |
| Composition | Adenosine 5'-diphosphate linked to nicotinamide riboside (β-NAD+) |
| Other names | Nadide; β-NAD; coenzyme I |
| Formula | C21H27N7O14P2 |
| Molecular weight | ~663.4 g/mol |
| CAS | 53-84-9 |
| PubChem CID | 5892 |
Lab reports
Lot reports for this product.
Each report names the lab, the lot, the test date and every assay run. Verify it on the lab's own portal.
| Lab | ILS Laboratories, San Diego, CA |
|---|---|
| Report type | Partner-facility report on the same batch Vortex stocks |
| Tested | 08/12/2026 |
| Net content | 511.02 mg |
| COA number | COA-2026-E9YRIU |
| Access code | DB9XXLKY |
Assays: Purity (HPLC), Identity (HPLC), Net content, Heavy metals (ICP-MS), Sterility (PCR), Endotoxin (USP <85>), Fentanyl screen
All published reports: lab report library →
Sources & references
Published literature.
Peer-reviewed papers on NAD+, linked to PubMed.
- Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors.
Lu W, Wang L, Chen L, et al.. Antioxid Redox Signal (2018). PubMed 28497978 → - Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites.
Trammell SA, Brenner C. Comput Struct Biotechnol J (2013). PubMed 24688693 → - Rapid quantitation of NAD(+)/NADH and NADPH/NADP(+) with mass spectrometry by using calibration constants.
Guo Q, Wang ML, Schwaiger-Haber M, et al.. Redox Biol (2026). PubMed 41389769 →
For in-vitro laboratory research use only by qualified researchers. Not for human or veterinary consumption. Not a drug, dietary supplement or cosmetic. These statements have not been evaluated by the FDA, and this product is not intended to diagnose, treat, cure or prevent any disease. This site does not provide medical advice. Literature listed above describes published research and is not a claim about this product. By purchasing, the buyer confirms the material is for laboratory research conducted by qualified personnel.
Research library
Further reading.
Identity, analysis and storage references from the Vortex research library.
